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Review Article
Intravascular oxygen sensors with novel applications for bedside
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Summary
Measurement allows us to quantify various parameters and variables in natural systems. In addition, by measuring the
effect by which a perturbation of one part of the system inﬂuences the system as a whole, insights into the functional
mechanisms of the system can be inferred. Clinical monitoring has a different role to that of scientiﬁc measurement.
Monitoring describes measurements whose prime purpose is not to give insights into underlying mechanisms, but to
provide information to ‘warn’ of imminent events. What is often more important is the description of trends in mea-
sured variables. In this article, we give some examples - focussed around oxygen sensors - of how new sensors can
make important measurements and might in the future contribute to improved clinical management.
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Measurement and monitoring
Measurement allows us to quantify various parameters
and variables in natural systems. In addition, by mea-
suring the effect by which a perturbation of one part
of the system inﬂuences the system as a whole, insights
into the functional mechanisms of the system can be
inferred. Measurement is therefore the toolkit of
science.
Clinical monitoring has a different role to that of
scientiﬁc measurement. Monitoring describes measure-
ments whose prime purpose is not to give insights into
underlying mechanisms, but to provide information to
‘warn’ of imminent events. In general, the accuracy of
data from clinical monitors is usually less important
than those of similar scientiﬁc instruments. This is
mostly because patient variables almost always have
more intrinsic variability, so in a measurement snap-
shot, we have no way of knowing, a priori, whether the
measured value deviates from an expected result because
of measurement inaccuracy, measurement imprecision,
patient variability or patient abnormality. What is often
more important is the description of trends in measured
variables. It is axiomatic that trends become more
readily apparent if the variance attributable to the
instrument is minimum (i.e. the measurements are pre-
cise). For this reason, although clinical monitors need
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not match the accuracy of similar scientiﬁc instruments,
they should have a high degree of precision.
Measuring the important vs. measuring
the measurable
Anaesthesia and critical care have seen monitoring
fashions come and go. In these environments, we tend
to want to believe in the importance of the variables
we can measure, but do not give much consideration
to those we cannot. This problem is widely acknowl-
edged in many areas of life. The US Defence Secretary
and military data analyst at the time of the Vietnam
war, Robert S McNamara, famously stated that ‘We
must avoid making what is measureable important and
ﬁnd ways to make the important measurable.’
As clinicians, we also build our understanding of
the basis of disordered physiology around what we
have in our measurement toolkit. So in a real sense,
what we can measure dictates what models we formu-
late, and this can be a problem for anyone wanting to
break free of orthodoxy. As Thomas Kuhn put it ‘ob-
servations are expected to be interpreted in the context
of the accepted paradigm thus restricting the periph-
eral vision of the researchers, since they reject the
observations if they do not ﬁt the model.’
In this article, we give some examples of how new
sensors can make important measurements that might
challenge the accepted wisdom, and might in the
future contribute to improved clinical management.
Dynamic blood gas analysis
Our understanding of the pulsatile nature of arterial
blood ﬂow in a distensible arterial tree means that we
can fully appreciate the added value of monitoring arte-
rial blood pressure dynamically by arterial cannulation
and a rapid response transducer system. All would agree
that identifying systolic and diastolic pressures, the
waveform and even its power spectrum provide impor-
tant information. No one would imagine that monitor-
ing the mean arterial pressure alone would be just as
valuable. Yet, when it comes to blood gas analysis, inter-
mittent sampling to provide a spot reading of mean
PaO2 is regarded as acceptable because it ﬁts with the
notion that PaO2 is not a dynamic variable, which is
consistent with the simple ‘balloon on a straw’ model of
the lung, based on continuous ventilation and perfusion
principles on which we were brought up [1]. What if,
under certain circumstances, PaO2 was as dynamic as
an invasive arterial blood pressure signal? What would
this tell us? How would we have to rethink our models
and understanding? Would we be interested?
Dynamic within-breath oscillations in PaO2 have
been reported in animal and human studies for the
past ﬁve decades [2–6]. The early studies attracted lit-
tle attention, but Williams et al. in 2000 [7], followed
by Baumgardner et al. in 2002 [2], noting that these
oscillations were more marked in the injured or atelec-
tatic lung, hypothesised that dynamic PaO2 signals
could have diagnostic potential. But this would require
us to revise our models of gas exchange.
At this time, gas exchange efﬁciency (which might
be simpliﬁed as the degree to which ventilation and
perfusion are directed away from the ideal alveolus,
and towards the alveolar dead-space or shunt compart-
ments, respectively) was considered to be constant in
the short term. Although this might vary as the
patient’s condition changed over hours or days, it was
considered to be a parameter (a quasi constant) rather
than a dynamic variable.
The proposition that in acute lung injury, PaO2
oscillations could be caused by the development of
atelectasis of dependent regions at end-expiration and
subsequent recruitment during each inspiration (cycli-
cal recruitment, CR) was modelled by Whiteley et al.
[8] and shown to be consistent with experimental
observations. Moreover, evidence in support of the
existence of CR had already been demonstrated in ani-
mal models of lung injury by other techniques such as
rapid sequence CT imaging by Hedenstierna’s group
[9] and by subpleural microscopy by Nieman’s group
[10]. The monitoring of PaO2 oscillations might there-
fore be a useful alternative indicator of this process,
and has the beneﬁt of being achievable at the bedside.
The clinical importance of this measurement is
that CR of atelectasis is thought to play a role in the
development of ventilator-induced lung injury, as the
shear stresses imparted by the alveolar expansion gen-
erate a cellular inﬂammatory response and so-called
atelectotrauma [11, 12]. Such an inﬂammatory trigger
may even be the driver to a systemic inﬂammatory
response [13]. If CR can be detected by rapid continu-
ous PaO2 measurement at the bedside, it has the
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potential to inﬂuence and personalise treatment. How-
ever, controversy exists with respect to the relative
contributions of CR and overdistension of normally
aerated and hyperinﬂated regions of lung in this
heterogeneous condition. Kavanagh showed in a rat
model of ARDS/ventilator-induced lung injury that the
major alveolar inﬂammatory response was localised
not in atelectatic regions but in non-dependent aerated
regions. Distal airway injury occurred in both depen-
dent and non-dependent regions alike [14]. Similarly,
Terragni et al. showed in human patients imaged with
CT, that those in whom tidal ventilation was predomi-
nantly distributed to hyperaerated lung regions (and
who also had larger areas of atelectasis) showed a
greater inﬂammatory response – as measured by pul-
monary cytokine concentrations – than those in whom
tidal ventilation was predominantly distributed to nor-
mally aerated lung (and who also had smaller areas of
atelectasis) [15]. Neither of these observations disprove
the potential of CR to induce local and distant injury,
but it is clear that hyperinﬂation elsewhere is poten-
tially equally injurious and often co-existent.
The technology of photonic oxygen
sensing
Traditionally, oxygen in the blood phase has been
measured by Clarke-type electrodes as are found in
bench blood gas analysers. Electrochemical methods
such as this are difﬁcult to deploy in vivo because of
problems of noise, drift and fouling of the sensing ele-
ment of the electrode by proteins and ﬁbrin micro-
aggregates. In recent years, optical or photonic sensing
technology has developed rapidly in a number of areas
including oxygen sensing. The Paratrend 7, a multipa-
rameter intravascular sensor using an early embodi-
ment of this technology, was developed by Diametrix
Medical (High Wycombe, UK) in the 1990s, but failed
to gain a market because, with its slow response time
(> 70 s), it was thought to offer little more than stan-
dard intermittent blood gas sampling or pulse oxime-
try. Rapid sensors designed for industrial use have
been used extensively in animal research, but no clini-
cally licensed intravascular sensor yet exists. Just as an
arterial blood pressure transducer requires a rapid
response in order to faithfully measure the arterial
waveform, so too does any potential dynamic PaO2
sensor, especially if required to track high respiratory
rates [16].
Photonic oxygen sensors exploit the property of
molecular oxygen to quench the quantal luminescence
emissions of certain excited luminophores. These lumi-
nescent dyes can be doped onto the tip of an optical
ﬁbre, which can be placed in a standard arterial cannula.
Pulsed high-energy light can be launched through the
ﬁbre waveguide to interact with the ﬂuorophore at the
distal tip as shown in Fig. 1. This excitation promotes
electrons within the sensing luminophore to higher
energy levels and as they return to ground state they
emit discrete photon packages at a lower energy. Typi-
cally, the ﬂuorescence decays away very rapidly with a
time constant in the order of microseconds. The higher
the ambient oxygen concentration, the greater the
quenching of this process – due to energy transfer con-
sequent on molecular collision – the shorter the decay
time constant and the weaker the light intensity signal.
The relationship between the intensity of the emitted
ﬂuorescence and the ambient oxygen concentration is
given by the Stern–Volmer equation:
I
I0
¼ 1
1þ kSV ½O2 ð1Þ
where I is the light intensity, I0 is the light intensity in
the absence of oxygen, kSV is the Stern–Volmer con-
stant and [O2] is the oxygen concentration in the sen-
sor matrix.
The emitted light is transmitted back down the
ﬁbre to a spectrophotometer where it can be measured.
Challenges to sensor design
There are a number of challenges in the design of
these optical oxygen sensors. First, for clinical use they
must be made of inert unbreakable material with a
non-toxic luminophore. Polymer ﬁbres and platinum
porphyrin-based luminophores fulﬁl this need. Such
ﬁbres can be 300–500 lm in diameter, which allows
them to be inserted into a standard arterial cannula
(see Fig. 1a,b). However, for such small sensors, the
amount of luminophore that can be accommodated on
the blunt tip end, and the amount of light that can be
launched, is limited, thereby limiting the signal-to-
noise ratio. The sensor design from [17] shown in
Fig. 1c overcomes this limitation to some extent by
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using a tapered tip design. Here, excitation light is
launched down the plastic ﬁbre core whose refractive
index is greater than that of the cladding layer. As a
result, the light undergoes total internal reﬂection (blue
arrows in Fig. 1c). On nearing the tip, however, the
ﬁbre is tapered in such a way as to distort the geome-
try of the reﬂective interface such that transmission
rather than internal reﬂection occurs and the light
now leaks from the core into the cladding. This taper
provides a larger surface area for interaction between
the excitation light and the luminophore, which is
embedded in a polymer matrix over the tapered
region. Much of the luminescent light (illustrated by
red arrows in Fig. 1c) is transmitted back down the
taper cladding and then into the ﬁbre core by a reverse
of the same process described.
One potential problem is that a small fraction of
the ﬂuorescent light, rather than returning directly
back down the ﬁbre, is emitted into the arterial blood
and is scattered by red cells. Some of this scattered
(a)
(b)
(c)
Figure 1 Micrograph of a tapered polymer ﬁbre tip. From [27], the sensor with Luer lock connector for insertion
into standard arterial cannula. Schematic of sensor design (see text for details). Modiﬁed from [17]
*Correction added on 6 January 2017, after ﬁrst online publication on 3 January 2017. Figure 1c has been replaced
due to some red arrows appearing outside the boundaries of the ﬁgure.
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light may be retransmitted back down the ﬁbre, but
this depends of the nature of the blood in which it sits
(i.e. the haemoglobin concentration and its saturation).
Consequently, the intensity of the ﬂuorescent light,
which is the variable of interest in Equation 1, may be
affected by factors other than the PaO2 itself. To over-
come this problem, rather than measuring light inten-
sity itself, Farmery et al. have adopted the technique of
measuring the time constant of the quantal lumines-
cence emissions themselves, which are solely a func-
tion of the oxygen concentration (or PaO2), and
therefore immune from inﬂuences from the sensed
medium.
The requirements for both speed and sensitivity of
the sensor are seemingly difﬁcult to reconcile. On the
one hand, in order for the luminophore to ‘see’ any
oxygen at all, we need to embed it in a matrix (the
polymer glue that sticks it to the sensor tip), which has
a high oxygen solubility. On the other hand, if the sen-
sor matrix has a high oxygen solubility, it will act as a
large oxygen reservoir which will slowly ﬁll and slowly
empty as the PaO2 rapidly steps up and down. Conse-
quently, this would give a very slow signal response.
These opposing requirements and properties have been
reconciled by the use of blends of copolymers with
large pendant side chains [17], which have a higher
intrinsic diffusivity, and by the addition of novel nanos-
tructures into the matrix which increase the diffusivity
and allow oxygen to remain at least partly in the gas
phase as it enters and leaves the sensing matrix (rather
than dissolving in the polymer and forming a reser-
voir). As a result, the sensors are capable of tracking
very rapid changes in PO2 in the liquid phase, as shown
in Fig. 2. In this study, a sensor was placed in an
extracorporeal circuit comprising two independent cir-
culations with high (30 kPa) and low PO2 (5 kPa).
Flow from each of these circulations was directed alter-
nately over the sensor by actuation of rapid solenoid
switch valves. It is not possible to quantify the response
time of the sensor with accuracy because the ﬂow
switch-over process itself is the rate limiting step, but it
is evident that even despite this, the rise time was of
the order of 100 ms. In the gas phase, these sensors can
have response times of less than 50 ms [18].
Observations of dynamic oxygen
signals in the normal and injured lung
– ‘normality’
Cyclical variations in alveolar gas composition have
long been understood to occur in normal physiology.
DuBois et al. predicted and modelled oscillations in
alveolar PCO2 (and by inference also PO2) throughout
the respiratory cycle in the normal lung [19], and
Band and Wolff demonstrated within-breath oscilla-
tions in arterial pH (a proxy for PCO2) in normal
man [20]. So if oscillations in PaO2 are a feature of
normal physiology, how are they different from those
generated by cyclical recruitment in the injured lung?
Figure 3 shows oscillations in PaO2 in an anaes-
thetised ventilated pig without lung injury, that is, with
as close to normal physiology as is possible under the
experimental conditions [21]. Here, oscillations in PaO2
corresponding to the respiratory cycle can clearly be
seen. Note that in apnoea at end-inspiration (Fig. 3a),
the decline in PaO2 is quite linear when haemoglobin is
almost saturated (PaO2 > 100 mmHg), but although
not shown here, the process becomes non-linear as the
inﬂection point of the oxyhaemoglobin dissociation
curve is approached (PaO2 < 100 mmHg).
The amplitude of the tidal PaO2 oscillation, and
the rate of fall in apnoea can be predicted by a simple
mass balance model proposed (for CO2 oscillations) by
Dubois et al. [19] and Edwards et al. [22]. In essence,
this is formulated from the assumption that the rate of
change in oxygen concentration in the alveolar com-
partment is the algebraic sum of the rate at which it is
added (or removed) by ventilation, and the rate of
uptake by the pulmonary circulation. During apnoea,
the rate of decline of PaO2, d(PaO2)/dt is given by the
following reduced form of the general equation:
Figure 2 Response of ﬁbre-optic oxygen sensor to near
step-changes in PO2 in the liquid phase. Sampling
points are at 10 Hz, that is, 100 ms intervals. From [17]
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dPaðtÞ
dt
¼ PB: _vO2VA þ VT ð2Þ
where PB is the barometric pressure, _vO2 is the rate of
oxygen uptake, VA is the lung volume at end-expira-
tion and VT is the tidal volume at the point of apnoea
(i.e. at end-inspiration VT=10 ml.kg
1 in Fig 3a).
The rates of apnoeic decline predicted by Equa-
tion 2 (based on independently measured values of _vO2
and VA) and those measured by the sensor show rea-
sonable agreement over a range of lung volumes and
oxygen uptake rates (unpublished results).
The peak to trough amplitude of the tidal oscillation
can be predicted as a ﬁrst approximation by assuming
that it is given by the product of the rate of decline in
expiration and the expiratory time. This can be deter-
mined from a modiﬁcation of Equation 2, where f is the
respiratory frequency and RIE is the I:E ratio:
DPaO2 ¼ PB 
_vO2
VAþVT 
1
f ð1þRIEÞ
¼ rate of decline in apnoea 1
f ð1þRIEÞ
ð3Þ
Figures 3a–c show continuous PaO2 recordings in
a healthy pig under different ventilatory conditions.
The observed peak-to-trough amplitudes of the tidal
oscillations agree approximately with values predicted
based on simple mass balance modelling from Equa-
tion 3.
Figures 3b and c show the mean PaO2 and the
amplitude of respiratory PaO2 oscillations during
mechanical ventilation with I:E of 1:2 (3b) and 2:1
(3c). The I:E of 2:1 was associated with greater mean
PaO2 level, and smaller amplitude of PaO2 respiratory
oscillations. Mean PaO2 increased from 113  22 (I:E
1:2) to 127  25 mmHg (I:E 2:1). The amplitude of
the PaO2 oscillations decreased from 28  6 (I:E 1:2)
to 21  5 mmHg (I:E 2:1).
The injured lung
It seems that certain deﬁning qualitative and quantita-
tive aspects of the respiratory PaO2 oscillations seen in
ARDS/acute lung injury distinguish them from those
that are part of normal physiology. In a saline lavage
rabbit model of ARDS, Baumgardner [2] demonstrated
intrabreath oscillations as wide as 400 mmHg
(100 mmHg trough, 500 mmHg peak) with an FIO2 of
1.0, even using a relatively slow optical sensor, so
clearly it is likely that ‘pathological oscillations’ might
be distinguished from ‘physiological’ ones by magni-
tude alone, especially since the expected physiological
Figure 3 Representative continuous measurements of PaO2 (top, black), pulmonary artery pressure (middle, light
grey) and airway pressure (bottom, dark grey) in a healthy pig, presented as a function of time. (a) Ventilation was
delivered in volume control mode, I:E ratio was 1:1, respiratory rate was 12 min1 and airway pressure ranged from
positive end-expiratory pressure of 5 cmH2O to end-inspiratory pressure of 10 cmH2O. (b) and (c) Ventilation was
delivered in pressure control mode (PC) with I:E ratios of 1:2 and 2:1, respectively. Respiratory rate was 6 min1,
and airway pressure ranged from positive end-expiratory pressure of 5 cmH2O to end-inspiratory pressure of
15 cmH2O. Data from experiments detailed in [21].
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magnitude can be calculated from estimates of oxygen
consumption, functional residual capacity (FRC) and
respiratory rate according to Equations 2 or 3. Sec-
ondly, Equation 2 tells us that the physiological oscilla-
tion is independent of the prevailing FIO2 or FAO2,
since neither of these variables feature in it. On the
other hand, if we propose that in ARDS/acute lung
injury, the PaO2 oscillations are due to cyclical changes
in shunt fraction resulting from cyclical recruitment/
derecruitment, then theoretical modelling predicts that
the PaO2 oscillation amplitude would vary as FIO2
(and hence FAO2) varies. This prediction is shown in
Fig. 4, which shows a simulation of the effect of vary-
ing FAO2 on the peak and trough of a PaO2 oscillation
in a scenario where shunt fraction is set to cycle from
30% at end-expiration to 10% at end-inspiration.
In the injured lung, the PaO2 signal does not fol-
low the predictions of Equations 2 and 3, and it is not
easily predictable. It can also show considerable
interindividual variation, which is not surprising given
the variable nature of ARDS/acute lung injury. The
signal may therefore provide a personalised insight
into a particular patient’s pathophysiology. The mecha-
nisms underlying the observed PaO2 changes through-
out the respiratory cycle have not been fully
established, but work to relate intrabreath PaO2
oscillations, and dynamic gas exchange is ongoing in
animal models of ARDS using rapid sequence CT
imaging and PET imaging of pulmonary blood ﬂow.
Figure 5 shows the dynamic PaO2 signal in a piglet
that has undergone repetitive washout of surfactant to
simulate ARDS. The FIO2 was 1.0, the respiratory rate
was relatively low (6 min1) [23], the I:E ratio is ini-
tially 1:4, exaggerating intrabreath oscillations. Here,
PaO2 oscillates between 100 mmHg and 300 mmHg,
and the rising signal is synchronous with lung inﬂa-
tion. This phenomenon is consistent with the idea that
cyclical recruitment and derecruitment might underlie
the PaO2 oscillations, as conﬁrmed by the changes in
the shape of the PaO2 trace when I:E is inverted. This
change is consistent with the possibility that the
shorter expiratory time lessens the derecruitment effect
and so moderates the PaO2 oscillation amplitude.
In other instances, the signal can behave differ-
ently. Figure 6, from Bodenstein et al. [24] shows a
record from a different animal, ventilated with FIO2 of
1.0, at 8 breaths.min1.
The Pa/FI ratio in this case is not dissimilar from
that shown in Fig. 5 (i.e. in both cases moderate gas
exchange impairment is evident), yet in Fig. 6 the
PaO2 signal has a seemingly paradoxical phase rela-
tionship with airway pressure, that is, PaO2 falls in
Figure 4 Predicted PaO2 oscillation peaks and troughs
as a function of FAO2 for the modelled scenario where
shunt fraction changes cyclically, breath by breath,
from 30% at end-expiration to 10% at peak inspira-
tion. Dotted lines show the envelopes of the peaks and
troughs of the oscillation.
Figure 5 Example of continuous PaO2 measurement
in experimental acute respiratory distress syndrome
(ARDS). Different inspiration to expiration (I:E) ratios
were studied during ongoing mechanical ventilation
(from [25]). MFPF, multi-frequency phase ﬂuorimetry.
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inspiration and rises in expiration. In practice, the
phase relationship is not easy to determine by eye
because the raw PaO2 signal, measured in the ascend-
ing aorta in these experiments, is usually a couple of
seconds delayed with respect to the airway pressure
signal, but it can be inferred from the changes in the
PaO2 signal in response to changes to the I:E ratio,
which can be imposed from time to time. Perhaps
counterintuitively at ﬁrst, it appears that the PaO2
trace has a relatively long peak, and a short trough
when the I:E ratio is 1:2. This trend is inverted when
the I:E ratio is inverted to 2:1. In this second example,
the effect of I:E reversal on the mean value of PaO2
and on the amplitude of PaO2 oscillations is not
apparent, possibly because the pigs were not surfactant
depleted, in contrast with the pigs studied in [25].
At the moment, the mechanism behind the para-
doxical phase relationship is in part speculative, but it
may involve redistribution of pulmonary blood ﬂow
due to pulmonary capillary compression in over-
stretched lung units, such that in inspiration ideal pul-
monary capillary ﬂow is reduced and shunt blood ﬂow
Figure 6 Example of inverted oxygen oscillations in a mechanically ventilated pig. The I:E of 1:2 is associated with a
long PaO2 peak and short trough, and vice-versa with the I:E of 2:1. Data from [24]
Figure 7 Potential multisource data input to computational model of individual patient lung dysfunction. Data from
dynamic PaO2, and the effect of cyclic pressure and distension changes on the waveform and phase relationship of
the signal, inform the model. Output from the model may then inform ventilator management.
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dominates. An analogous form of this phenomenon
has been demonstrated with the worsening of arterial
oxygenation following a recruitment manoeuvre in a
sheep lavage model of acute lung injury, studied at a
low time resolution with positron emission tomogra-
phy [26].
Conclusions
Rapid PaO2 sensing by a small plastic ﬁbre-optic sensor
capable of being inserted into a standard arterial can-
nula, has the potential to change the way clinicians
understand disordered gas exchange in patients with
lung injury. The condition is heterogeneous throughout
the lung, and highly variable both between patients and
within individual patients at different time points in
their illness. Static blood gas analysis and assessment of
PaO2/FIO2 ratio are too insensitive to characterise the
complex and unique sets of circumstances that conspire
to produce the observed gas exchange deﬁcits in ARDS
patients. Less likely still is a ‘one size ﬁts all’ approach to
ventilator management, based on routine bedside mea-
surements, to beneﬁt all patients. More work is needed
to invert individual patients’ dynamic PaO2 data to cre-
ate an individualised model of the prevailing dysfunc-
tion at any particular moment. The next challenge is to
develop a computational model informed by an array of
different sensing inputs from a number of sources,
including dynamic PaO2, to provide the clinician with
real-time information on a patient’s gas exchange efﬁ-
ciency and its responsiveness. This system might be
informed by other data such as airway pressure, volume
(and particularly the effect that cyclic changes in pres-
sure and distension have on the dynamic PaO2 signal),
FRC and information on spatial aeration from modali-
ties such as electrical impedance tomography, as pro-
posed in Fig. 7.
With guidance from dynamic PaO2 sensing, venti-
lator management might be tailored to minimise cycli-
cal recruitment/derecruitment where it exists, or to
avoid unnecessary and excessive PEEP and recruitment
manoeuvres where these are shown to be ineffective.
Dynamic PaO2 sensing also has the potential to detect
when excessive pressure or distension of already aer-
ated lung impairs blood ﬂow to the ‘ideal alveolus’,
allowing better informed choices of PEEP, respiratory
rate, and I:E ratio.
We have come a long way from considering that
ventilation and gas exchange are steady-state continu-
ous processes like those occurring at a ﬁsh’s gills. The
tools are being developed to expand our vision of
dynamic gas exchange just as rapid arterial pressure
transducers opened the way to examine dynamic pulse
waveforms. The challenge now is to allow our under-
standing of the pathophysiology to catch up with the
state of the art toolbox.
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